OrthoPediatrics Reports Q3 Revenue Beat and Record Adjusted EBITDA Despite EPS Miss
OrthoPediatrics (NASDAQ: KIDS) reported third-quarter financial results characterized by strong top-line growth and record profitability metrics, despite missing non-GAAP earnings per share expectations. The company achieved revenue of $72.7 million, representing an 18.8% increase year-over-year and exceeding analyst estimates by $4.2 million. While the non-GAAP EPS of -$0.23 fell short of consensus by $0.02, the company reached a record adjusted EBITDA of $6.9 million for the quarter. This marks an improvement over the $6.2 million reported in the third quarter of 2025, signaling strengthening operational efficiency amidst its revenue expansion.
Tickers: $KIDS
Topics: earnings miss EBITDA growth revenue beat